| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2177 | 2015 |
| Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 MP Bonaca, DL Bhatt, PG Steg, RF Storey, M Cohen, K Im, ... European heart journal 37 (14), 1133-1142, 2016 | 199 | 2016 |
| Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial G Magnani, RF Storey, G Steg, DL Bhatt, M Cohen, J Kuder, K Im, ... European heart journal 37 (4), 400-408, 2016 | 119 | 2016 |
| ITALIAN CANCER FIGURES-REPORT 2015: The burden of rare cancers in Italy= I TUMORI IN ITALIA-RAPPORTO 2015: I tumori rari in Italia S Busco, C Buzzoni, S Mallone, A Trama, M Castaing, F Bella, R Amodio, ... Epidemiologia e prevenzione 40 (1, suppl. 2), 1-120, 2016 | 116 | 2016 |
| Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial MP Bonaca, DL Bhatt, TO Ophuis, PG Steg, R Storey, M Cohen, J Kuder, ... JAMA cardiology 1 (4), 425-432, 2016 | 113 | 2016 |
| Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54 MP Bonaca, RF Storey, P Theroux, PG Steg, DL Bhatt, MC Cohen, KA Im, ... Journal of the American College of Cardiology 70 (11), 1368-1375, 2017 | 104 | 2017 |
| Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis G Savarese, RP Giugliano, GMC Rosano, J McMurray, G Magnani, ... JACC: Heart Failure 4 (11), 870-880, 2016 | 95 | 2016 |
| Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: a subgroup analysis … A Franzone, R Piccolo, G Gargiulo, S Ariotti, M Marino, A Santucci, ... JAMA cardiology 1 (7), 795-803, 2016 | 92 | 2016 |
| Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48 G Magnani, RP Giugliano, CT Ruff, SA Murphy, F Nordio, M Metra, ... European journal of heart failure 18 (9), 1153-1161, 2016 | 88 | 2016 |
| Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the U nited S tates G Magnani, MP Bonaca, E Braunwald, AJ Dalby, KAA Fox, SA Murphy, ... Journal of the American Heart Association 4 (3), e001505, 2015 | 86 | 2015 |
| Italian cancer figures, report 2014: prevalence and cure of cancer in Italy MS Adamo, D Alessi, P Aletta, R Amodio, S Andreone, T Angelin, ... Epidemiologia e prevenzione 38 (6), 1-122, 2014 | 72 | 2014 |
| Timing of complete revascularization with multivessel PCI for myocardial infarction BE Stähli, F Varbella, A Linke, B Schwarz, SB Felix, M Seiffert, R Kesterke, ... New England Journal of Medicine 389 (15), 1368-1379, 2023 | 64 | 2023 |
| I TUMORI IN ITALIA-RAPPORTO 2013: Tumori multipli= ITALIAN CANCER FIGURES-REPORT 2013: Multiple tumours M Adamo, D Alessi, P Aletta, R Amodio, S Andreone, T Angelin, ... Epidemiologia e prevenzione 37 (4-5, suppl. 1), 1-152, 2013 | 55 | 2013 |
| P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects O De Filippo, F D’Ascenzo, S Raposeiras-Roubin, E Abu-Assi, ... European Heart Journal-Cardiovascular Pharmacotherapy 6 (1), 31-42, 2020 | 44 | 2020 |
| Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: insights from the RENAMI … F D'Ascenzo, M Bertaina, F Fioravanti, F Bongiovanni, ... European journal of preventive cardiology 27 (7), 696-705, 2020 | 39 | 2020 |
| Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor M Bianco, F D'ascenzo, SR Roubin, T Kinnaird, M Peyracchia, ... International journal of cardiology 301, 200-206, 2020 | 36 | 2020 |
| Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 RHM Furtado, JC Nicolau, G Magnani, K Im, DL Bhatt, RF Storey, PG Steg, ... European heart journal 41 (17), 1625-1632, 2020 | 35 | 2020 |
| Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention … R Piccolo, G Magnani, S Ariotti, G Gargiulo, M Marino, A Santucci, ... EuroIntervention 13 (1), 78-86, 2017 | 31 | 2017 |
| Real-world data of prasugrel vs. ticagrelor in acute myocardial infarction: results from the RENAMI registry O De Filippo, M Cortese, F D´ Ascenzo, S Raposeiras-Roubin, E Abu-Assi, ... American Journal of Cardiovascular Drugs 19, 381-391, 2019 | 28 | 2019 |
| Predictors, type, and impact of bleeding on the net clinical benefit of long‐term ticagrelor in stable patients with prior myocardial infarction G Magnani, D Ardissino, KA Im, A Budaj, RF Storey, PG Steg, DL Bhatt, ... Journal of the American Heart Association 10 (4), e017008, 2021 | 27 | 2021 |
Marc Bonaca MD MPHProfessor of Medicine, University of Colorado School of Medicine在 cpcmed.org 的电子邮件经过验证
